BioCentury
ARTICLE | Clinical News

Bilastine regulatory update

November 23, 2015 8:00 AM UTC

Taiho submitted an NDA in Japan for bilastine to treat allergic rhinitis, urticaria and itching resulting from skin diseases, including eczema/dermatitis, prurigo and cutaneous pruritus. The histamin...